Craig Michael Pine Net Worth & Insider Trades

Craig Michael Pine - Chief Corp Dev.&Strat. Officer, Eyepoint Pharmaceuticals, Inc

As of December 6, 2023

What is Craig Michael Pine's Net Worth?

The current estimated net worth of Eyepoint Pharmaceuticals, Inc's Chief Corp Dev.&Strat. Officer, Craig Michael Pine, is estimated to be about $1M . Craig Michael Pine owns about 5,343 units of Eyepoint Pharmaceuticals, Inc common stock. In the last year at Eyepoint Pharmaceuticals, Inc, Craig Michael Pine has sold an estimated value of $990K worth.

What is Craig Michael Pine's Past Insider Trading?

Craig Michael Pine's largest purchase order was 45,000 units , worth over $567.9K on December 6, 2023. Craig Michael Pine's largest sale order was 45,000 units , worth over $990K on December 6, 2023. In total, Craig Michael Pine has made about 6 transactions over a year of their time at Eyepoint Pharmaceuticals, Inc. Craig Michael Pine usually trades in January, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Craig Michael Pine

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Craig Michael Pine's' Mailing Address?

  • Mailing address is C/o Eyepoint Pharmaceuticals, Inc. 480 Pleasant Street, Suite A-210 Watertown MA 02472 MA

Eyepoint Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Nancy Lurker 2020 $581,957 - $482,460 $563,216 $454,508 $15,660 $2,097,801
Nancy Lurker 2019 $577,037 - $650,207 $693,165 $144,034 $15,340 $2,079,783
George Elston 2020 $440,000 - - $83,104 $236,940 $15,660 $775,704
George Elston 2019 $58,385 $20,000 - $635,555 - $2,068 $716,008
Dario Paggiarino 2020 $436,156 - $158,864 $185,417 $242,371 $15,660 $1,038,468
Dario Paggiarino 2019 $420,862 - - $275,775 $105,188 $15,340 $817,165
Scott Jones 2020 $376,250 - $158,864 $185,417 $212,135 $15,660 $948,326
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm

What are Eyepoint Pharmaceuticals, Inc's Past Insider Trades?

Eyepoint Pharmaceuticals, Inc's most recent insider trade came on December 7, 2023 by Ye Liu who sold 1,000,000 units worth $19.51M . In the last 5 years, insiders at Eyepoint Pharmaceuticals, Inc have sold an estimated value of $30.67M and bought an estimated value of $64.79M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Nancy Lurker, Executive Vice Chair,  Dario Paggiarino, Chief Medical Officer,  and Jay Duker, President and CEO .

EyePoint Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...